发布网友
发布时间：2022-04-20 09:02
共1个回答
热心网友
时间：2023-08-04 09:36
季加孚教授先后于国内外学术期刊发表论文100余篇，总影响因子达130.7，编写和编译学术著作8部。培养硕士、博士研究生，博士后40余人。曾获北京市科学技术进步三等奖、科技部优秀论文奖等奖励，以及北京市总工会经济技术创新标兵、中国抗癌协会先进工作者等荣誉称号 。
代表性论文：
1.Xiao-Hong Wang, Lian-Hai Zhang, Xi-Yao Zhong, Xiao-Fang Xing, Yi-Qiang Liu, Zhao-Jian Niu, Yong Peng, Hong Du, Gui-Guo Zhang, Ying Hu, Ni Liu, Yu-Bing Zhu, Shao-Hua Ge, Wei Zhao, Ai-Ping Lu, Ji-You Li, Jia-Fu Ji. S100A6 overexpression associates with poor prognosis and is epigenetically up-regulated in gastric cancer. American Journal of Pathology. 2010 (Accepted)
2.Ni Liu, Lian-hai Zhang, Hong Du, Ying Hu, Gui-guo Zhang, Xiao-hong Wang, Ji-you Li, and Jia-fu Ji. Overexpression of Endothelial Cell Specific Molecule-1 (ESM-1) in Gastric Cancer. Annals of Surgical Oncology. 2010 (Accepted)
3.Li ZY, Tang L, Zhang LH, Bu ZD, Wu AW, Wu XJ, Zong XL, Wu Q, Shan F, Li SX, Ren H, Zhang XP, Ji JF. Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study. Med Oncol. 2009 Dec 5. [Epub ahead of print]
4.Jia SQ, Niu ZJ, Zhang LH, Zhong XY, Shi T, Du H, Zhang GG, Hu Y, Su XL, Ji JF. Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics. J Cancer Res Clin Oncol. 2009; 135(3):403-411
5.Wu A, Ji J. Adjuvant chemotherapy for gastric cancer or not: a dilemma? J Natl Cancer Inst. 2008;100(6):376-377.
6.Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology. 2008;52(5):560-568.
7.Meng H, Tanigawa N, Hao CY, Dai DJ, Lu CD, Ji JF. Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer. Hepatogastroenterology. 2007;54(79):1934-1940.
8.Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol. 2006;32(5):473-483.
9.Hao CY, Lu AP, Xing BC, Huang XF, Gao F, Ji JF. Solid pseudopapillary tumor of the pancreas: report of 8 cases in a single institution and review of the Chinese literature. Pancreatology. 2006;6(4):291-296
10.Zhang LH, Tian B, Diao LR, Xiong YY, Tian SF, Zhang BH, Li WM, Ren H, Li Y, Ji JF. Dominant expression of 85-kDa form of cortactin in colorectal cancer. J Cancer Res Clin Oncol. 2006;132(2):113-120.
11.Guo DL, Zhang J, Yuen ST, Tsui WY, Chan AS, Ho C, Ji J, Leung SY, Chen X. Reced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis. 2006;27(3):454-464
12.Zhang LH, Ji JF. Molecular profiling of hepatocellular carcinomas by cDNA microarray. World J Gastroenterol. 2005;11(4):463-468.
13.Zhang J, Su XQ, Wu XJ, Liu YH, Wang H, Zong XN, Wang Y, Ji JF. Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol. 2003;9(12):2658-2661.
14.Chen X, Leung SY, Yuen ST, Chu KM, Ji JF, Li R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003;14(8):3208-3215.
15.Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji JF, Chan AS, Li R, Law S, Troyanskaya OG, Tu IP, Wong J, So S, Botstein D, Brown PO. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A. 2002;99(25):16203-16208.
16.Ji JF, Chen X, Leung SY, Chi JT, Chu KM, Yuen ST, Li R, Chan AS, Li J, Dunphy N, So S. Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene. 2002;21(42):6549-6556.
17.Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji JF, Dudoit S, Ng IO, Van De Rijn M, Botstein D, Brown PO. Gene expression patterns in human liver cancers. Mol Biol Cell. 2002;13(6):1929-1939.
会议摘要：
1.Ji JF, Li ZY, Zong XL, Wu XJ, Wu Q, Bu ZD, Wang Y. Oxaliplatin-based regimen as neoadjuvant chemotherapy for Chinese patients with advanced gastric cancer: Preliminary results of a phase II study. 2004 ASCO Annual Meeting Proceedings. Vol 22, No 14S, 2004: 4184
2.Ji JF, Wu AW, Liu YH, Zhang ZT, Wang S, Ye YJ, Li R, Li ZX, Li ZY. Oxaliplatin + 5-fluorouracil/leucovorin (FOLFOX7) as neoadjuvant plus adjuvant treatment versus adjuvant alone in locally advanced resectable gastric cancer: BJSA-01 study design and interim results. 2007 Gastrointestinal Cancers Symposium Abstract No: 39
3.Jia-fu Ji; Xi-yao Zhong; Lian-hai Zhang. OR-10-006 (ORAL PRESENTATION)- Overexpression of mrp14 in gastric carcinoma: correlation with lymph node metastasis and TNM stages. May 10, 2007 International Gastric Cancer Congress (IGCC) Sao Paulo, Brazil